Company Data
Denali Therapeutics Inc.
Ticker
DNLI
Current Price
$21.59 -2.88%
Market Cap
$3.1B
Price Target
Refer to Report
Volume
784.1K
52wk Range
$14.56 - $33.33
Overview
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company’s development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson’s disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.